Number of employees: 1-5
Investors: Albert Azout
Provider of hardware and software used to monitor patient's risk of heart failure. The company provides digital health software and hardware intended to give actionable data for the management of congestive heart failure.
The device users are patients suffering from congestive heart failure (CHF). Our solution, once FDA approved, will be prescribed to these individuals by a physician for remote patient monitoring, and we will bill insurance / Center for Medicare Services a monthly subscription fee per patient.
The Respirix solution is non-invasive and we aim to facilitate remote, at-home monitoring of CHF patients at a substantially lower cost than our competitors, without requiring a surgical procedure, and with equivalent or superior accuracy.